Navigation Links
Bioclinica’s Michael O’Neal Honored on 2019 PharmaVOICE 100 List
Date:8/4/2019

Bioclinica, a leading provider of science and technology expertise to assist the life science industry in advancing the development of medical therapies, announced today that Michael O’Neal, M.D., Chief Medical Officer, Head of Oncology, has been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People in the Life-Sciences Industry.” Dr. O’Neal was recognized for his leadership at Bioclinica and his contributions to the field of medical imaging in oncology clinical trials over his 30-year career.

“Dr. O’Neal is a true leader and expert in medical imaging for clinical trials; and he inspires his colleagues and clients every day,” said David Herron, President & CEO of Bioclinica. “During his 17 years with Bioclinica, he has developed and championed improved standards that enable research sites to produce comparable study data across the globe, which is essential to successful trials and regulatory approvals of new therapies.”

Drawing on extensive clinical training in internal medicine and diagnostic radiology, Dr. O’Neal provides leadership to Bioclinica’s on-staff radiologists, oncologists, and clinical project management teams. He works closely with sponsors and their teams to ensure the latest industry criteria are operationalized so that imaging is performed according to the study protocol for every patient a site enrolls. Dr. O’Neal’s team currently manages more than 600 active oncology clinical trials.

The PharmaVOICE 100 list, published annually, celebrates inspirational, motivational, and transformative individuals in life sciences who positively impact their colleagues, peers, organizations, and the industry.

About Bioclinica
Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's cloud-based offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance and trial management. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers a global network of research sites and patient recruitment services to provide committed, detail-focused service through all stages of drug development. The company's thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Read the full story at https://www.prweb.com/releases/bioclinicas_michael_oneal_honored_on_2019_pharmavoice_100_list/prweb16482561.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Slone Partners, Where People Are Our Science®, Places Michael Mercer as Chief Commercial Officer at Karius
2. Visikol Co-Founder Michael Johnson named to 2017 Forbes 30 Under 30 List
3. Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinsons
4. BUSMs Michael F. Holick receives American Society for Bone and Mineral Research award
5. TGen Dr. Michael Barrett awarded $200,000 grant at national cancer conference in San Diego
6. EyeLock Appoints Michael Fiorito Vice President of Enterprise Accounts
7. Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam
8. Distinguished Cardiologists and Scientists Honored with 2018 International Academy of Cardiology Awards at the 23rd World Congress on Heart Disease
9. Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach
10. Two UT Arlington professors honored by Indian colleagues
11. UCLA professor honored for expanding our understanding of tropical forests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded ... to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded ...
(Date:7/19/2019)... ... 2019 , ... VetStem Biopharma has long been a leader in ... result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed a worldwide ... VetStem should be able to fast-track this cancer therapy for use in dogs ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:7/30/2019)... ... 2019 , ... The summer season has been super busy ... has the company already hosted many of its signature cooking classes and team-building ... , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy a variety of ...
(Date:7/19/2019)... Calif. (PRWEB) , ... July 18, 2019 , ... ... also known as “Ravi Everest,” will be joining forces with California-based charity Coalition ... held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular ...
(Date:7/11/2019)... , ... July 11, 2019 , ... At the most ... complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans ... , The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research ... physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. ... characteristic differentiation peak, change in crystallite size , Over 142% increase in ...
Breaking Biology Technology: